VTRS — Viatris Inc. stock price and chart

VTRS

Viatris Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · Nasdaq Composite 0.04% · S&P 500 0.03% · Russell 1000 0.03% · US Stock Market 0.03% · Russell 3000 0.03%

$16.95-1.05%

as of market close, Sep 18, 2026

☾ AH $16.95 +0.00%

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDD

20162019202120242026

10.015.020.025.030.035.040.045.00100.0M200.0M$16.95

2026-09-18

Price$16.95

MA20$16.24

MA50$13.47

Vol38.2M

What would $1,000 invested in VTRS be worth today? →

VTRS returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $16.95
Change YTD: +36.14%
Next earnings: Nov 5, 2026
Market cap: 19.5B2018-12 14.2B2026-09 19.5B+37.6% over the window
Enterprise value: 32.2B
Shares outstanding: 1.1B2018-12 516.5M2026-06 1.1B+122.4% over the window
52W low: $9.43
52W high: $18.39
From 52W high: -7.83%
From 52W low: +79.75%
52W range: 84%
Beta: 0.90

Volume

Rel volume: 1.79×
30D volume: 8.8M
30D $ vol: 144.7M

Fundamentals

Sales (ttm): 14.7B2018-12 11.3B2026-06 14.7B+30.4% over the window
Sales/share: $12.792018-12 $21.822026-06 $12.79-41.4% over the window
FCF (ttm): 2B2018-12 2.1B2026-06 2B-6.5% over the window
FCF/share: $1.702018-12 $4.052026-06 $1.70-57.9% over the window
Book value/share: $12.422018-12 $23.562026-06 $12.42-47.3% over the window
Debt / equity: 0.81×2020-12 0.982026-06 0.81-16.7% over the window
Current ratio: 1.582019-12 1.212026-06 1.58+30.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +4.47%2025-06-30 → 2026-06-3014.1B → 14.7B (+4.5% total)-1.90%2023-06-30 → 2026-06-3015.6B → 14.7B (-5.6% total)-1.06%2021-06-30 → 2026-06-3015.5B → 14.7B (-5.2% total)n/a
FCF: +11.62%2025-06-30 → 2026-06-301.8B → 2B (+11.6% total)-3.58%2023-06-30 → 2026-06-302.2B → 2B (-10.4% total)+3.13%2021-06-30 → 2026-06-301.7B → 2B (+16.7% total)n/a
Shares: -1.48%2025-06-30 → 2026-06-301.2B → 1.1B (-1.5% total)-1.44%2023-06-30 → 2026-06-301.2B → 1.1B (-4.2% total)-1.02%2021-06-30 → 2026-06-301.2B → 1.1B (-5.0% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share: +6.04%2025-06-30 → 2026-06-30$12.06 → $12.79 (+6.0% total)-0.47%2023-06-30 → 2026-06-30$12.97 → $12.79 (-1.4% total)-0.04%2021-06-30 → 2026-06-30$12.82 → $12.79 (-0.2% total)n/a
FCF/share: +13.30%2025-06-30 → 2026-06-30$1.50 → $1.70 (+13.3% total)-2.18%2023-06-30 → 2026-06-30$1.82 → $1.70 (-6.4% total)+4.20%2021-06-30 → 2026-06-30$1.39 → $1.70 (+22.8% total)n/a
Book value/share: -7.04%2025-06-30 → 2026-06-30$13.36 → $12.42 (-7.0% total)-10.60%2023-06-30 → 2026-06-30$17.38 → $12.42 (-28.5% total)-6.67%2021-06-30 → 2026-06-30$17.54 → $12.42 (-29.2% total)n/a
Dividend/share: +0.00%2025-06-30 → 2026-06-30$0.48 → $0.48 (+0.0% total)+0.00%2023-06-30 → 2026-06-30$0.48 → $0.48 (+0.0% total)+8.69%2021-12-31 → 2026-06-30$0.33 → $0.48 (+45.5% total)n/a
Price: +71.97%2025-09-18 → 2026-09-18$9.86 → $16.95 (+71.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+19.95%2023-09-18 → 2026-09-18$9.82 → $16.95 (+72.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+4.55%2021-09-17 → 2026-09-18$13.57 → $16.95 (+24.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-8.63%2016-09-16 → 2026-09-18$41.79 → $16.95 (-59.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +78.07%2025-09-18 → 2026-09-18$9.52 → $16.95 (+78.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+25.09%2023-09-18 → 2026-09-18$8.66 → $16.95 (+95.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+9.04%2021-09-17 → 2026-09-18$11.00 → $16.95 (+54.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-6.55%2016-09-16 → 2026-09-18$33.37 → $16.95 (-49.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 135.6×2018-12 15.632026-09 -223.01-1527.0% over the window
Fwd P/E: 6.5×
P/S (ttm)Market cap ÷ TTM revenue.: 1.3×2018-12 1.262026-09 1.32+5.5% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.4×2018-12 1.162026-09 1.37+17.4% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 10.0×2018-12 6.772026-09 9.96+47.1% over the window
EV/EBITDA (fy): 11.9×
EV/Sales (ttm): 2.2×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 10.04%2018-12 14.8%2026-06 10.5%-28.6% over the window
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 2.83%
Dividend/share (fwd): $0.48
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 1.15B ÷ 1.17B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 1.48%
Shareholder yield (realized, 1y)Realized buyback yield + dividends paid over the same year ÷ the market cap at the start of that year — cash received per dollar an owner actually held. Both figures come from the company's own SEC filings.: 4.32%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($300.5M) ÷ today's market cap ($19.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 1.54%2018-12 3.1%2026-06 1.6%-46.9% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $300.5M + TTM dividends $0) ÷ today's market cap ($19.5B). Same caveat as the cash buyback yield.: 1.54%2018-12 3.1%2026-06 1.6%-46.9% over the window

Vs own 10Y history

P/E: 94th
P/OI: 93rd
P/S: 95th
P/B: 99th
P/FCF: 88th

Bar = where today’s multiple sits in VTRS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-1.05%

+2.67%

+4.82%

+10.28%

YTD

+36.14%

+71.91%

+24.91%

Financial statements

Open full VTRS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	-5.94%	+0.04%
JNJ	Johnson & Johnson	-0.41%	-0.09%
ABBV	AbbVie Inc.	+1.95%	-0.02%
MRK	Merck & Co. Inc.	+8.66%	-0.19%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	-4.32%	+0.45%
TMO	Thermo Fisher Scientific Inc.	+10.60%	-1.04%
AMGN	Amgen Inc.	-9.32%	+1.55%
GILD	Gilead Sciences Inc.	+4.65%	-0.52%

Viatris Inc. (VTRS) trades at $16.95 with a live price and an interactive chart covering 46+ years of daily price history, plus key valuation metrics. ChartRow also publishes VTRS’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full VTRS financial statements →

VTRS — Viatris Inc. price, chart and key statistics